Basaglar Kwik Pen

Composition

Insulin glargine 100 IU/mL (3 mL prefilled pen)

Uses of Basaglar Kwik Pen

Treatment of diabetes mellitus to improve glycaemic control in adults and children where basal insulin is required (Type 1 diabetes as part of a basal-bolus regimen; Type 2 diabetes when oral agents are inadequate or insulin is indicated).

• •Provides 24-hour basal insulin coverage
• •Lowers fasting blood glucose
• •Helps improve HbA1c control
• •Once-daily dosing convenience
• •Suitable for Type 1 and Type 2 diabetes as prescribed

How it works

Insulin glargine is a long-acting basal insulin analogue. After subcutaneous injection it forms microprecipitates that slowly release insulin, providing a near-constant insulin level for about 24 hours to reduce fasting and between-meal blood glucose.

Directions for use

For subcutaneous injection only using the pen, once daily at the same time each day. Inject into abdomen, thigh or upper arm and rotate injection sites; do not inject into a vein or muscle. Can be taken with or without food; dose is individualized by the doctor—do not change dose/brand without medical advice.

Side effects

Common side effects of Basaglar Kwik Pen may include:

• •Hypoglycaemia
• •injection site reactions (pain/redness/swelling/itching)
• •lipodystrophy